Thrivent Financial for Lutherans’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $351M | Buy |
|
|||||
|
2025
Q1 | $328M | Sell |
|
|||||
|
2024
Q4 | $363M | Buy |
|
|||||
|
2024
Q3 | $379M | Buy |
|
|||||
|
2024
Q2 | $331M | Buy |
|
|||||
|
2024
Q1 | $181M | Buy |
|
|||||
|
2023
Q4 | $62.4M | Sell |
|
|||||
|
2023
Q3 | $61.3M | Sell |
|
|||||
|
2023
Q2 | $56.2M | Buy |
|
|||||
|
2023
Q1 | $27.1M | Buy |
|
|||||
|
2022
Q4 | $28.6M | Sell |
|
|||||
|
2022
Q3 | $28.3M | Sell |
|
|||||
|
2022
Q2 | $29.4M | Sell |
|
|||||
|
2022
Q1 | $42.1M | Sell |
|
|||||
|
2021
Q4 | $39.2M | Sell |
|
|||||
|
2021
Q3 | $45.5M | Sell |
|
|||||
|
2021
Q2 | $45.3M | Sell |
|
|||||
|
2021
Q1 | $37.7M | Sell |
|
|||||
|
2020
Q4 | $43M | Sell |
|
|||||
|
2020
Q3 | $46.6M | Buy |
|
|||||
|
2020
Q2 | $35.4M | Buy |
|
|||||
|
2020
Q1 | $19.4M | Buy |
|
|||||
|
2019
Q4 | $11.3M | Sell |
|
|||||
|
2019
Q3 | $9.78M | Buy |
|
|||||
|
2019
Q2 | $9.64M | Sell |
|
|||||
|
2019
Q1 | $19.3M | Sell |
|
|||||
|
2018
Q4 | $39.5M | Buy |
|
|||||
|
2018
Q3 | $36M | Sell |
|
|||||
|
2018
Q2 | $29.5M | Sell |
|
|||||
|
2018
Q1 | $26.8M | Buy |
|
|||||
|
2017
Q4 | $11.8M | Buy |
|
|||||
|
2017
Q3 | $7.9M | Buy |
|
|||||
|
2017
Q2 | $3.21M | Buy |
|
|||||
|
2017
Q1 | $3.14M | Buy |
|
|||||
|
2016
Q4 | $2.54M | Buy |
|
|||||
|
2016
Q3 | $2.63M | Buy |
|
|||||
|
2016
Q2 | $2.44M | Buy |
|
|||||
|
2016
Q1 | $2.12M | Buy |
|
|||||
|
2015
Q4 | $2.35M | Buy |
|
|||||
|
2015
Q3 | $2.23M | Buy |
|
|||||
|
2015
Q2 | $2.18M | Sell |
|
|||||
|
2015
Q1 | $3.34M | Buy |
|
|||||
|
2014
Q4 | $3.12M | Sell |
|
|||||
|
2014
Q3 | $2.98M | Buy |
|
|||||
|
2014
Q2 | $2.72M | Buy |
|
|||||
|
2014
Q1 | $2.54M | Buy |
|
|||||
|
2013
Q4 | $2.11M | Sell |
|
|||||
|
2013
Q3 | $93.5M | Buy |
|
|||||
|
2013
Q2 | $90.7K | Buy |
|